Allergy Nasal Spray Kills Cold and CoVid Viruses
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Allergy Nasal Spray Kills Cold and CoVid Viruses
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Vidcast: https://www.instagram.com/p/DOwe9yfDnI2/
Azelastine nasal spray, marketed as Astepro but also available as a generic, can reduce your chances of developing a CoVid infection by a factor of 3 and cut your chances of developing a common cold by a factor of 3.5. German researchers at Saarland University recently published their double-blind, placebo-controlled study of 450 participants in the JAMA Internal Medicine Journal.
Half the subjects received azelastine 0.1% nasal spray three times a day for 56 days. The control subjects used a similarly-appearing but inactive nasal spray. Respiratory infections were confirmed using PCR analyses. The results showed that only 2.2% of the azelestine sprayers developed CoVid compared with 6.7% of controls. Only 1.8% of azelestine sprayers developed rhinovirus infections compared with 6.3% of controls.
Generic azelastine spray is a prescription medication. Astepro Spray, the same medication, is available over-the-counter. If you think you might benefit, give it a try.
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2838335
#azelastine #astepro #allergy #CoVid #rhinovirus #commoncold